Axplora is a prominent Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO) that specialises in delivering high-quality active pharmaceutical ingredients (APIs) on time and at scale. Formed from the merger of Farmabios, Novasep, and PharmaZell, Axplora combines a wealth of expertise and operates across nine industrial sites. The company offers a wide range of specialized technologies, including hazardous chemistry, chromatography, antibody-drug conjugates (ADCs), steroids, continuous processes, lipids, and highly potent active pharmaceutical ingredients (HPAPIs). With a commitment to providing reliable and agile solutions, Axplora serves both innovators and generic API products in the pharmaceutical industry.

Services include:
- Small Molecule
- Biologics
- Drug Substance Manufacturing (API)
- Research & Development
- Analytical Methods Development
- Contract Development and Manufacturing (CDMO)

Axplora is dedicated to excellence in the pharmaceutical manufacturing sector, ensuring that clients benefit from their extensive capabilities and multi-site capacity. For more information, please visit axplora.com.